STAND. COM. REP. NO. 142

 

Honolulu, Hawaii

                  

 

RE:    S.B. No. 1333

       S.D. 1

 

 

 

Honorable Ronald D. Kouchi

President of the Senate

Thirty-First State Legislature

Regular Session of 2021

State of Hawaii

 

Sir:

 

     Your Committee on Health, to which was referred S.B. No. 1333 entitled:

 

"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"

 

begs leave to report as follows:

 

     The purpose and intent of this measure is to remove cannabidiol drugs that have been approved by the United States Food and Drug Administration from the list of Schedule V substances for consistency with federal laws.

 

     Your Committee received testimony in support of this measure from Greenwich Biosciences, Inc.

 

     Your Committee finds that section 329—11, Hawaii Revised Statutes, requires that the State's list of controlled substances comport with the list of controlled substances under federal law.  Your Committee further finds that Food and Drug Administration recently approved the prescription drug Epidiolex, and generic versions of that drug which is a plant-derived prescription cannabinoid product used to treat seizures associated with certain types of epilepsy, including rare and difficult to treat forms of childhood-onset epilepsy.  This measure brings state law in conformity with federal law by removing approved cannabidiol drugs from the State's schedule V list of controlled substances.

 

     Your Committee has amended this measure by making technical, nonsubstantive amendments for the purposes of clarity and consistency.

 

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1333, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 1333, S.D. 1, and be referred to your Committee on Judiciary.

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

 

 

________________________________

JARRETT KEOHOKALOLE, Chair